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Objectives: Complex brachiocephalic disease involves multiple vessels and is frequently associated with multisystem
atherosclerosis. We reviewed surgical outcome and examined the impact of this problem on decision making regarding
operative staging, technique, and choice of conduit.
Methods: Between 1966 and 2000, 157 consecutive patients (mean age, 54.0 years; 48.4% male) with innominate artery
or multivessel brachiocephalic disease underwent operative reconstruction using either a transthoracic approach (group
A, n  113) or a less invasive, extrathoracic approach (group B, n  44). Reconstruction required multiple distal
anastomoses in 70 patients (44.6%), concomitant coronary artery bypass grafting (CABG) in 37 patients (23.6%), and
concomitant carotid endarterectomy (CEA) in 26 patients (16.6%).
Results:No significant differences were found between group A and group B when operative mortality (2.7% vs 2.3%) and
stroke rates (2.7% vs 6.8%) were analyzed. However, 10 years after surgery, freedom from graft failure was significantly
better in group A (94.4% 4.4%) than in group B (60.3% 13.4%) (P .002). Freedom from graft failure was adversely
affected by nonaortic inflow (P  .002) and axillo-axillary cervical grafts (P  .0001). Mortality and stroke rates for
subgroups having multiple distal anastomoses (2.9%, 2/70 and 4.3%, 3/70), concomitant CABG (5.4%, 2/37 and 0,
0/37), and concomitant CEA (3.8%, 1/26 and 3.8%, 1/26) were similar to those of other patients. For the entire patient
group, 10-year rates of actuarial freedom from specific events were death, 68.8%  6.0%; myocardial infarction, 86.7% 
4.5%; stroke, 87.0%  4.4%; coronary revascularization, 88.0%  3.6%, and other vascular operation, 79.9%  4.4%.
Conclusions: Transthoracic arch reconstruction for complex brachiocephalic disease can be done with acceptably low
morbidity and mortality similar to those of a less invasive, extrathoracic approach. Furthermore, the transthoracic
approach is associated with significantly better long-term freedom from graft failure, possibly because it preserves aortic
inflow to the great vessels. Nonetheless, the high frequency of late events in this relatively young patient population
reflects the presence of multisystem atherosclerosis and suggests the need for close follow-up and lifestyle modification.
(J Vasc Surg 2005;42:47-54.)Brachiocephalic disease may involve multiple great ves-
sels and is frequently associated with major, concomitant
atherosclerotic disease involving other organ systems.1,2
Concomitant multivessel, multisystem atherosclerosis may
affect the outcome of surgical interventions for brachioce-
phalic disease and influence decision making regarding
operative staging, approach, technique, and choice of con-
duit. In this report, we examine whether a transthoracic or
a cervical (extrathoracic) approach affects either operative
mortality and morbidity or long-term freedom from graft
failure after brachiocephalic reconstruction in patients with
innominate, multivessel, ormultisystem disease. To explore
these issues, we reviewed our 35-year experience with treat-
ing this problem.
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We reviewed the records of 157 consecutive patients
(mean age, 54.0 years; 48.4% male) treated for atheroscle-
rotic innominate artery (IA) and multivessel brachioce-
phalic disease at our institution between January 1966 and
June 2000. Of this group, 113 patients (group A) under-
went operative reconstruction with a transthoracic ap-
proach, and 44 patients (group B) underwent reconstruc-
tion with a less invasive, extrathoracic approach. Patients
with brachiocephalic disease resulting from either inflam-
matory arteritides or radiation exposure were excluded.
When necessary, supplemental information was obtained
from the patient’s private physician and family. Demo-
graphic and clinical characteristics of the patients are sum-
marized in Table I.
All patients presented with symptomatic disease that
affected their lifestyle. In patients with isolated brachioce-
phalic disease, our criteria for intervention were concomi-
tant brachiocephalic symptoms and angiographic evidence
of one or more specific culprit lesions. In patients with
concomitant, multisystem disease, our criteria were symp-
tomatic coronary or carotid disease and severe, asymptom-
atic or symptomatic brachiocephalic disease.
Brachiocephalic disease was diagnosed incidentally in
three patients (1.9%) who did not have brachiocephalic
symptoms. Two of these patients had angina caused by
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neurologic symptoms secondary to carotid bifurcation dis-
ease.
The specific brachiocephalic presenting symptom could
not be documented in three very early patients because of
poor chart documentation and patient inability to recall
distant events. However, each of these three patients had
objective documentation of an upper extremity blood pres-
sure differential and angiographic confirmation of severe
brachiocephalic disease.
Cerebrovascular insufficiency was documented in 133
patients (84.7%), and upper extremity vascular insufficiency
or emboli were found in 49 patients (31.2%) (Table II). In
patients with stable cardiac status, hemodynamic changes
and symptoms of ischemia in the upper extremities were
reproduced with the method described by Grosveld et al.3
Ultrasonic duplex scanning, with hemodynamic measure-
ments before and after exercise, was performed to differen-
tiate hemodynamically significant and nonsignificant le-
sions. Cerebral hemisphere symptoms were classified with
the Clinical presentation, History, site of Arterial disease,
Target organ [brain] (CHAT) system described by Baker et
Table I. Demographic, clinical, and operative characterist
Characteristic(s)
Group A
(n  113)
Male (%) 53 (46.9)
Female (%) 60 (53.1)
Age (y) 53.3
Age range (y) 31-81
Risk factors
Hypertension (%) 61 (54.0)
Diabetes (%) 11 (9.7)
Known PVOD (%) 61 (54.0)
Tobacco use (%) 51 (45.1)
Previous MI (%) 18 (15.9)
Known CAD (%) 57 (50.4)
Hyperlipidemia (%) 9 (8.0)
COPD (%) 8 (7.1)
Angina (CCS class)*
II (%) 11 (9.7)
III (%) 18 (15.9)
IV (%) 8 (7.1)
Operative characteristics
Operative priority
Elective (%) 105 (92.9)
Urgent (%) 7 (6.2)
Emergent (%) 1 (0.9)
Redo CABG (%)* 4 (3.5)
IABP (%)* 3 (2.7)
Left main (%)* 14 (12.4)
EF  45% (%)* 9 (8.0)
Failed PTCA (%)* 1 (0.9)
LIMA (%)* 7 (6.2)
NS, Not significant; PVOD, peripheral vascular occlusive disease; MI, my
pulmonary disease; CCS, Canadian Cardiovascular Society; Redo CABG, rep
Left main, native left main coronary artery disease; EF, ejection fraction; PTC
artery to anterior coronary artery bypass.
Group A, transthoracic bypass; Group B, extrathoracic bypass.
*Applies only to the subgroup that underwent concomitant brachiocephalial (Table II).4 Exercise electrocardiography, thallium stresstesting, or dipyridamole infusion imaging was used to assess
myocardial perfusion and to document ischemia in patients
with stable angina or increased cardiac risk.
All patients underwent full invasive radiologic evalua-
tion, including arch aortography with runoff views of the
carotid, subclavian, and vertebral circulations and cinean-
giography of the coronary vessels where indicated. Vessel
stenosis was determined angiographically with the follow-
ing formula: [1 – (diameter at point of greatest stenosis/
diameter at point of greatest patency in the normal vessel)]
 100%. Significant stenosis in the brachiocephalic vascular
distribution was defined as a narrowing of the vessel lumen
by 80%.
Atherosclerotic disease was present in the IA in 150
(95.5%) of the 157 patients, in the right subclavian artery
(SCA) in 48 (30.6%), in the right common carotid artery
(CCA) in 48 (30.6%), in the left CCA in 38 (24.2%), and in
the left SCA in 26 (16.6%). In the 150 patients with IA
disease, 48 (32.0%) required individual reconstruction of
both the right SCA and the right CCA because of distal IA
disease, and 44 (29.3%) required reconstruction of the
right SCA, the right CCA, and one or both left arch vessels
Group B
(n  44)
Total
(n  157) P value
23 (52.3) 76 (48.4) NS
21 (47.7) 81 (51.6) NS
57.6 54.0 NS
36-71 31-81
27 (61.4) 88 (56.1) NS
6 (13.6) 17 (10.8) NS
22 (50.0) 83 (52.9) NS
18 (40.9) 69 (43.9) NS
10 (22.7) 28 (17.8) NS
22 (50.0) 79 (50.3) NS
2 (4.5) 11 (7.0) NS
7 (15.9) 15 (9.6) NS
— 11 (7.0)
— 18 (11.5)
— 8 (5.1)
44 (100.0) 149 (94.9)
0 (0) 7 (4.5)
0 (0) 1 (0.6)
— 4 (2.5)
— 3 (1.9)
— 14 (8.9)
— 9 (5.7)
— 1 (0.6)
— 7 (4.5)
ial infarction; CAD, coronary artery disease; COPD, chronic obstructive
ronary artery bypass grafting; IABP, intra-aortic balloon counterpulsation;
cutaneous transluminal coronary angioplasty; LIMA, left internal mammary
nstruction and CABG.ics
ocard
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volving only the left arch vessels.
Thirty-seven patients (23.6%) had concomitant, symp-
tomatic CAD requiring coronary artery bypass grafting
(CABG). In each case, brachiocephalic disease was diag-
nosed incidentally after the patient reported having angina.
Thirty-five of these patients (96.6%) also had brachioce-
phalic symptoms. Occlusive disease at the carotid bifurca-
tion requiring concomitant carotid endarterectomy (CEA)
was present in 20 (17.8%) of the 113 group A patients and
in six (13.6%) of the 44 group B patients. In 25 (96.2%) of
the 26 patients with concomitant brachiocephalic disease
and carotid bifurcation disease, symptoms specific to bra-
chiocephalic disease were distinct from symptoms related to
carotid bifurcation disease.
In group A, 51 (45.1%) of the 113 patients required
two to four distal anastomoses (mean, 2.7 per patient), 37
(32.7%) required concomitant CABG (mean, 2.5 grafts per
patient), and 20 (17.7%) required concomitant CEA. Of all
157 patients in groups A and B, 70 (44.6%) required two to
four distal anastomoses (mean, 2.5 per patient), 37 (23.6%)
required concomitant CABG (mean, 2.5 grafts per pa-
tient), and 26 (16.6%) required concomitant CEA.
Operative interventions were classified as elective, ur-
gent, and emergent (Table I). Urgent operations were
defined as procedures performed in patients whose acceler-
ated symptoms necessitated immediate hospital admission
and whose conditions were too unstable to allow hospital
discharge before operative intervention. Emergent opera-
tions were defined as procedures performed in patients with
accelerated symptoms, whose conditions were so unstable
that immediate operative intervention was required.
Our operative techniques for reconstruction of the
great vessels have been reported previously.1,5,6 Bypass
procedures were performed by using a transthoracic or an
Table II. Presenting symptoms of brachiocephalic lesions
Symptom type
Group A
(n  113)
Cerebrovascular†
A  carotid ocular (%) 2 (1.8)
B  carotid cortical (%) 23 (20.4)
C  vertebrobasilar (%) 22 (19.5)
A  B (%) 7 (6.2)
A  C (%) 13 (11.5)
B  C (%) 25 (22.1)
Total (%) 92 (81.4)
Upper extremity
Claudication (%) 37 (32.7)
Microembolization (%) 2 (1.8)
Total (%) 39 (34.5)
Coronary‡
Angina (%) 1 (0.9)
Asymptomatic/indeterminate (%) 4 (3.5)
Group A, transthoracic bypass; Group B, extrathoracic bypass.
*Symptoms classified by vascular territory. Some patients had multiple sym
†Cerebral hemispheric symptoms were classified using the Clinical presenta
‡Caused by coronary-subclavian steal.extrathoracic approach. The transthoracic approach in-volved either a median sternotomy incision or a minimally
invasive technique. The choice of operative method and
approach was initially guided by the distribution of disease
as determined by preoperative angiography, aortic calcifi-
cation, clinical assessment of operative risk, patient prefer-
ence, and surgeon preference.
In all cases, the primary goal was to completely revas-
cularize all areas affected by occlusive disease. Over the time
frame of the study, transthoracic direct revascularization
that provides inflow from the aorta was found to produce
salutary outcomes with minimal morbidity, which led to its
preferential use.
Perioperative myocardial infarction was defined as the
development of new Q waves, an elevated myocardial frac-
tion of creatine kinase in association with persistent ST-
segment changes, or the development of new conduction
abnormalities. Perioperative stroke was defined as develop-
ment of new neurologic focal change on physical examina-
tion, with infarction confirmed by computed tomography.
After hospital discharge, each patient underwent clini-
cal, hemodynamic, and noninvasive vascular examinations
every 6 months if asymptomatic or immediately if symp-
tomatic. Each patient received an ultrasound duplex exam-
ination of the brachiocephalic and vertebral vessels using
the method described by Grosveld.3 Extremity exercise was
standardized (1.5 W/s for 5 minutes) by means of an
ergonomic apparatus. An examination was considered pos-
itive if any of the following were detected: new or recurrent
vertebrobasilar, hemispheric, or coronary (related to coro-
nary subclavian steal syndrome) symptoms or signs; a de-
crease of 0.15 in the blood pressure index of the ipsilat-
eral arm compared with the contralateral arm; reversal of
flow in the ipsilateral vertebral or carotid artery; or CCA
vessel evaluation indicating a marked serial increase in
velocity (130 cm/s), a marked serial decrease in internal
Group B
(n  44)
Total
(n  157) P value
1 (2.3) 3 (1.9) NS
11 (25.0) 34 (21.7) NS
14 (31.8) 36 (22.4) NS
5 (11.4) 12 (7.6) NS
1 (2.3) 14 (8.9) NS
9 (20.5) 34 (21.7) NS
41 (93.2) 133 (84.7) NS
12 (27.3) 49 (31.2) NS
0 (0) 2 (1.3) NS
12 (27.3) 51 (32.5) NS
0 (0) 1 (0.6) NS
2 (4.5) 6 (3.8) NS
.
istory, site of Arterial disease, Target organ [brain] (CHAT) system.4*
ptomscarotid artery/CCA velocity ratio, or spectral broadening.
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occlusive or ulcerated proximal plaque is occasionally pos-
sible. Before ultrasound technology was incorporated,
screening and follow-up examinations relied solely upon
hemodynamic and clinical evaluation. A positive screening
or follow-up examination result led to mandatory aortic
arch and four-vessel cerebral angiography in each case.
Graft failure was defined as angiographic demonstration of
recurrent stenosis (80%, or 80% with recurrent symp-
toms) in a single bypass graft or in any limb of a multiple-
conduit bypass.
Patient age, gender, preoperative risk factors, and pre-
senting symptoms were analyzed by group with 2 analysis.
Operative results were analyzed for each group and sub-
group by using Fisher’s exact test. Operative results by
decade were analyzed for all patients and for groups with 2
analysis. Long-term follow-up of the 153 survivors totaled
754.6 patient years, with a mean of 5.1  0.5 years per
patient for group A (range, 0.25 to 22.0 years) and 4.5 
0.7 years per patient for group B (range, 0.25 to 16.0
years). To evaluate the long-term results, actuarial curves
were obtained by means of Kaplan-Meier statistical analysis
using Statistical Analysis Systems (SAS) software (SAS In-
stitute, Cary, NC).
RESULTS
The patients were relatively young (mean age, 54.0
years) and had clinical manifestations of multisystem ath-
erosclerosis. In addition to atherosclerotic disease of the
brachiocephalic system, 83 patients (52.9%) had known
disease of the carotid bifurcation, abdominal aorta, or lower
extremity vascular distribution. Concomitant coronary ar-
tery disease was present in 79 patients (50.3%), including
37 (23.6%) who underwent simultaneous coronary and
brachiocephalic revascularization. No significant differ-
ences were found between groups with respect to age,
gender, preoperative risk factors, or symptoms.
Operative mortality was similar between group A
(2.7%) and group B (2.3%). Although stroke rates were not
significantly different between the two groups (2.7% vs
6.8%), the trend of higher stroke rates in patients who had
cervical approach reconstructionmay be related to the need
for manipulation and clamping of both CCAs. Four oper-
ative deaths were among the immediate and late postoper-
Table III. Operative and late results
Outcome
Group A
(n  113
Mortality (%) 3 (2.7)
Stroke (%) 3 (2.7)
Myocardial infarction (%) 2 (1.8)
10-y survival (%) 68.5  7
10-y freedom from graft failure (%) 94.4  4
Group A, transthoracic bypass; Group B, extrathoracic bypass.
*P  0.002 versus group A.ative adverse events (Table III): 2 after a stroke, 1 after amyocardial infarction, and 1 after a respiratory arrest that
occurred 12 days after surgery. These operative deaths were
associated with the concomitant brachiocephalic recon-
struction and CABG subgroup in two patients, the trans-
thoracic reconstruction subgroup that required multiple
distal anastomoses in one patient, and with an extrathoracic
bypass in one patient.
There were six operative strokes, including the two fatal
ones. Five of these occurred in the hospital; the sixth
occurred after discharge from the hospital but within 30
days of the operative procedure. All hospital strokes were
ipsilateral and embolic in origin. This was confirmed in each
case by either immediate operative re-exploration or ultra-
sound examination of vessel flow. The perioperative stroke
that occurred after hospital discharge was most likely a
contralateral stroke, given the reported symptoms. A post-
mortem examination was not performed in that patient,
however. Operative outcomes were not significantly differ-
ent across decades.
Patterns of failure were similar in each group. In indi-
vidual patients, graft failure occurred after thrombosis of
either the entire graft or an individual graft limb and led to
recurrent symptoms related to the distribution of the cir-
culation supplied by the thrombosed graft or graft seg-
ment. In each case, the recurrent symptoms were similar to
those that occurred preoperatively. Five graft failures oc-
curred in group A, of which four were caused by thrombo-
sis in a single limb of a multivessel conduit. Seven graft
failures occurred in group B, of which two were caused by
thrombosis in a single segment of a multisegment conduit.
Late graft failure was less common after transthoracic
approach reconstructions than after extrathoracic approach
reconstructions (Fig, Table III). Contributing to the graft
failure in the extrathoracic group (group B) were nonaortic
inflow (P  .002) and the use of axillo-axillary or axillo-
axillary-CCA grafts (P  .0001). Of the seven episodes of
restenosis that occurred in group B, five occurred among
the 12 patients who received axillo-axillary  CCA grafts,
whereas only two occurred among the 26 patients who
received CCA-CCA or CCA-CCA-SCA grafts and none
occurred in six patients who received SCA-contralateral
CCA grafts. The construction of SCA-contralateral CCA
grafts in these patients was necessitated by complete occlu-
sion of the remaining brachiocephalic vessels and severe
Group B
(n  44)
Total
(n  157)
1 (2.3) 4 (2.5)
3 (6.8) 6 (3.8)
0 (0) 2 (1.3)
69.5  11.1 68.8  6.0
60.3  13.4* 84.6  5.4)
.2
.4disease within the contralateral CCA. However, the CCA-
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cantly) higher perioperative stroke rate of 7.7% (2/26).
This trend, as suggested earlier, may be related to the need
for manipulation and serial clamping of both carotid arter-
ies in order to perform this type of graft. The use of multiple
distal anastomoses to completely reconstruct all brachioce-
phalic disease was not a risk factor for late brachiocephalic
restenosis in either group A or group B.
We identified subgroups and analyzed each to deter-
mine whether the increased technical demands of complete
reconstruction affected either operative outcome or long-
term graft failure. The performance of multiple distal anas-
tomoses, concomitant CABG, or concomitant CEA did
not appear to affect operative outcome in group A or in the
population as a whole. In group A, the 51 patients who had
multiple distal anastomoses experienced one death (2.0%)
and two strokes (3.9%), the 37 patients who had concom-
itant BC reconstruction and CABG had two deaths (5.4%)
and no strokes, and the 20 patients who had concomitant
CEA had one death (5.0%) and one stroke (5.0%). Among
the 157 patients in both group A and group B, the 70
patients who had multiple distal anastomoses had two
deaths (2.9%) and three strokes (4.3%), the 37 patients who
had concomitant CABG had two deaths (5.4%) and no
strokes, and the 26 patients who had concomitant CEA had
one death (3.8%) and one stroke (3.8%).
For group A, 10-year actuarial brachiocephalic freedom
from graft failure was similar for all subgroups regardless of
the operative need for single distal anastomotic reconstruc-
tion (93.3%  6.4%), multiple distal anastomotic recon-
struction (92.3%  7.4%), concomitant CABG and bra-
chiocephalic reconstruction (100.0%), or concomitant
Transthoracic approach in 113 patients (A) versus extrat
actuarial freedom from graft failure over time. Graft failur
limb of a multivessel conduit, that is, stenosis 80%, o
indicate standard deviations 10%.CEA and brachiocephalic reconstruction (93.3%  6.7%).Within group A, long-term (10-year) actuarial survival
for patients who had only brachiocephalic reconstruction
that required a single distal anastomosis (72.8%  13.6%)
was similar to that of patients who had only brachiocephalic
reconstruction that required multiple distal anastomoses
(71.1%  10.6%). A trend towards decreased survival was
noted for patients having concomitant CABG (60.7% 
11.9%), however. Of the 31 late deaths among all patients,
20 (64.5%) were cardiac related. Late events after surgery
are summarized in Table IV.
DISCUSSION
There is substantial controversy regarding the appro-
priate staging and specific operative techniques for individ-
ual patients with brachiocephalic disease and concomitant
multivessel, multisystem atherosclerosis. Berguer et al7,8
advocate extrathoracic reconstruction for asymptomatic
patients and discourage concomitant brachiocephalic re-
construction and CABG for patients with both brachioce-
phalic disease and CAD. Other studies suggest that either
bypass or endarterectomy techniques, when used during
transthoracic reconstruction, may provide a safe and dura-
ble treatment for multivessel disease.9-12
Each transthoracic technique maintains proximal in-
flow from the aorta, which may account for the excellent
long-term freedom from graft failure that has been re-
ported in recent series using either technique.9,12 Although
each technique may provide excellent results in patients
whose lesions are anatomically suited to these procedures,
one technique may be preferable to the other in specific
situations. Transthoracic endarterectomy is of limited use-
fulness for treating panmural arteritides, radiation injury,
ic approach in 44 patients (B). Life-table distribution of
defined as recurrent stenosis in the entire graft or in any
0% with associated recurrent symptoms. Hatched lineshorac
e was
r 8distal vessel occlusive disease, and diffuse multivessel dis-
n.
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hamper the placement of a bypass conduit.1
As shown in this study, extrathoracic bypass is associ-
ated with inferior long-term freedom from graft failure
when used to treat IA or multivessel brachiocephalic dis-
ease. Although nonaortic inflow contributes to this finding,
the superior long-term freedom from graft failure achieved
by extrathoracic bypass for single-vessel brachiocephalic
disease suggests that other factors may be involved.14,15
The present study suggests that axillo-axillary  CCA
cervical grafts adversely influence long-term freedom from
graft failure. Although other cervical grafts also showed a
trend towards less freedom from graft failure, the subgroup
of patients without axillo-axillary  CCA grafts showed a
worrisome trend towards increased perioperative stroke
that may be due to the need for manipulation and serial
clamping of both CCAs.
Within treatment groups, patients with IA disease and
multivessel brachiocephalic disease had similar operative
outcomes and long-term freedom from graft failure. This
finding suggests that complete revascularization of all dis-
ease is valid despite the technical demands of performing
multiple distal anastomoses, additional proximal anastomo-
ses to a bifurcated graft, and concomitant CABG, CEA, or
both.
The higher incidence of left SCA and left CCA disease
in our patients compared with those found in other large
studies may be due to several factors. Because proximal
SCA disease may affect internal mammary artery (IMA)
coronary conduit flow, it is standard policy at this institu-
tion to screen the proximal SCA in all patients having
cineangiography during evaluation of the coronary arteries.
If proximal SCA disease is found at that time, all arch vessels
are screened by angiography. This policy resulted in the
discovery of several cases of brachiocephalic disease in
patients whose brachiocephalic-disease-related symptoms
were either mild or unappreciated. In addition, outside
clinicians’ knowledge of our interest in brachiocephalic
reconstruction has increased the number of patients with
brachiocephalic disease referred to this institution.
As the long-term results of endovascular intervention
continue to be elucidated, the differences in outcome be-
tween surgical and endovascular management of brachio-
cephalic disease will be defined. It is not yet known whether
Table IV. Late (10-year) freedom from specific events
Event
Group A
(n  113)
Death 68.5  7.2%
Graft failure 94.4  4.4%
Myocardial infarction 85.0  5.5%
Stroke 84.7  5.8%
Coronary revascularization 91.9  3.5%
Other vascular procedure* 77.7  5.4%
Group A, transthoracic bypass; Group B, extrathoracic bypass.
*Vascular intervention on a system other than the brachiocephalic circulatioeither type of management has specific advantages withregard to long-term freedom from graft or intervention
failure, safety, initial and late cost, patient satisfaction,
efficacy for single-vessel versus multivessel disease, or effi-
cacy for treatment of concomitant brachiocephalic disease
and CAD, carotid bifurcation disease, or both. Among
patients with single-vessel brachiocephalic disease at this
and other institutions, midterm freedom from graft or
intervention failure is lower after endovascular intervention
than after operative bypass.16-18
We are currently following with interest the long-term
results of endovascular intervention in patients who re-
quired concomitant reconstruction of multiple brachioce-
phalic vessels. In six such patients at this institution, the rate
of freedom from graft failure is 50% at a mean follow-up of
3.2 years per patient.
As shown in this study, concomitant operative recon-
struction of the brachiocephalic and coronary systems can
be accomplished with acceptably low operative morbidity
and mortality. This finding is confirmed by other studies of
smaller patient populations.19,20 However, although we
found low mortality in patients who had concomitant
brachiocephalic reconstruction and CABG, Berguer et al7
report 29% mortality in their series of seven such patients.
That study differed from the present study, however, in that
its patient population was much smaller and somewhat
older (mean age, 61 years) and two independent operative
teams (cardiothoracic and vascular) separately recon-
structed the coronary and brachiocephalic systems.
Despite the good outcomes of simultaneous recon-
struction of multisystem disease in this study, asymptom-
atic, severe disease in one system and concomitant symp-
tomatic disease in the other can probably be treated safely
with staged procedures, as suggested by Berguer.7,8 Deci-
sions about the timing and approach to be used with an
individual patient must ultimately be based on the experi-
ence of the institution, the patient’s particular risk factors,
and the severity of the disease.
We are currently examining with interest the trend of
decreased long-term survival in the concomitant bra-
chiocephalic reconstruction and CABG subgroup, which
has occurred despite the excellent long-term freedom
from brachiocephalic graft failure in this group. It is
possible that factors other than multisystem atheroscle-
rosis and its consequences are contributing to this out-
Group B
(n  44)
Total
(n  157)
69.5  11.1% 68.8  6.0%
60.3  13.4% 84.6  5.4%
91.2  6.6% 86.7  4.5%
92.7  4.1% 87.0  4.4%
78.1  8.9% 88.0  3.6%
86.5  6.8% 79.9  4.4%come. For example, evidence is substantial that the IMA
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isolated conduit for single-vessel CAD or in combination
with vein conduits for multivessel CAD.21 However,
concomitant brachiocephalic disease involving the prox-
imal SCA has long been considered to contraindicate
IMA use, in that it may adversely affect IMA flow.22,23 As
a result, surgeons at this and other institutions have
traditionally used all-vein conduits in patients with con-
comitant brachiocephalic disease.
Nonetheless, the safety of concomitant brachioce-
phalic reconstruction and CABG and the durability of
brachiocephalic bypass have led us to examine the poten-
tial benefits of using the IMA conduit in these patients
after brachiocephalic reconstruction of the SCA. We
have used IMA conduits after concomitant brachioce-
phalic reconstruction in a limited population of seven
patients and found no early complications. Long-term
follow-up is ongoing.
Although the current study is nonrandomized and
retrospective, it is one of the largest and longest to deal with
this topic. Despite its relatively large population compared
with other studies of innominate, multivessel, and multi-
system brachiocephalic disease, its statistical power (1 –
type II error), which reflects the potential for type II error
(determined primarily by the total number of patients in
the study), is 52%. We agree with Burnand’s statement24
that it is unlikely a randomized, prospective trial of treat-
ments for complex brachiocephalic disease will ever be
performed, given the relative infrequency of this severe
pattern of disease. In that regard, the findings of this report
may prove useful to those clinicians who encounter patients
with such disease.
Although changes in anesthesia, monitoring tech-
niques, and perioperative care have occurred over the
course of the study, the consistently good outcomes likely
reflect the uniformity in treatment philosophy, approaches,
methods, and surgical techniques employed in the treat-
ment of brachiocephalic disease over the course of the
study. This is a direct result of the influence of one of the
authors (D.A.C.), who has been at our institution since its
founding.
We conclude that transthoracic arch reconstruction for
IA and multivessel brachiocephalic disease, whether per-
formed alone or concomitantly with CABG or CEA, is
associated with acceptably lowmorbidity andmortality that
do not differ significantly from those of a less invasive,
extrathoracic approach. Furthermore, transthoracic arch
reconstruction has significantly better long-term freedom
from graft failure, possibly because it maintains aortic in-
flow to the great vessels. Despite excellent long-term graft
durability, the frequency of late events in this relatively
young population reflects the presence of multisystem ath-
erosclerotic disease and supports the need for close fol-
low-up and lifestyle modification.
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